RT Journal Article SR Electronic T1 A self-management programme for COPD: a randomised controlled trial JF European Respiratory Journal JO Eur Respir J FD European Respiratory Society SP 1538 OP 1547 DO 10.1183/09031936.00047814 VO 44 IS 6 A1 Mitchell, Katy E. A1 Johnson-Warrington, Vicki A1 Apps, Lindsay D. A1 Bankart, John A1 Sewell, Louise A1 Williams, Johanna E. A1 Rees, Karen A1 Jolly, Kate A1 Steiner, Michael A1 Morgan, Mike A1 Singh, Sally J. YR 2014 UL http://erj.ersjournals.com/content/44/6/1538.abstract AB Studies of programmes of self-management support for chronic obstructive pulmonary disease (COPD) have been inconclusive. The Self-Management Programme of Activity, Coping and Education (SPACE) FOR COPD is a 6-week self-management intervention for COPD, and this study aimed to evaluate the effectiveness of this intervention in primary care. A single-blind randomised controlled trial recruited people with COPD from primary care and randomised participants to receive usual care or SPACE FOR COPD. Outcome measures were performed at baseline, 6 weeks and 6 months. The primary outcome was symptom burden, measured by the self-reported Chronic Respiratory Questionnaire (CRQ-SR) dyspnoea domain. Secondary outcomes included other domains of the CRQ-SR, shuttle walking tests, disease knowledge, anxiety, depression, self-efficacy, smoking status and healthcare utilisation. 184 people with COPD were recruited and randomised. At 6 weeks, there were significant differences between groups in CRQ-SR dyspnoea, fatigue and emotion scores, exercise performance, anxiety, and disease knowledge. At 6 months, there was no between-group difference in change in CRQ-SR dyspnoea. Exercise performance, anxiety and smoking status were significantly different between groups at 6 months, in favour of the intervention. This brief self-management intervention did not improve dyspnoea over and above usual care at 6 months; however, there were gains in anxiety, exercise performance, and disease knowledge. A brief self-management programme for COPD improves some patient outcomes; however, more support may be required http://ow.ly/AbCpm